We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.51B
AUM Growth
-$404M
Cap. Flow
-$428M
Cap. Flow %
-6.58%
Top 10 Hldgs %
75.64%
Holding
128
New
5
Increased
10
Reduced
80
Closed
2

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$11.9M
2
BABA icon
Alibaba
BABA
+$4.81M
3
HOLX
Hologic
HOLX
+$3.59M
4
HDB icon
HDFC Bank
HDB
+$3.33M
5
BIIB icon
Biogen
BIIB
+$2.36M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$215M
2
V icon
Visa
V
+$93.1M
3
ECL icon
Ecolab
ECL
+$55.1M
4
PM icon
Philip Morris
PM
+$14.8M
5
GILD icon
Gilead Sciences
GILD
+$5.81M

Sector Composition

Rank Sector Weight
1 Financials 30.37%
2 Consumer Discretionary 18.72%
3 Communication Services 15.06%
4 Healthcare 14.55%
5 Materials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
51
Zimmer Biomet
ZBH
$18.6B
$6.5M 0.1%
61,428
– –
PRTK
52
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6.48M 0.1%
498,253
-116,647
-19% -$1.74M
CI icon
53
Cigna
CI
$78.8B
$6.16M 0.09%
36,723
-22,054
-38% -$4.29M
SRPT icon
54
Sarepta Therapeutics
SRPT
$1.64B
$4.98M 0.08%
67,272
-33,206
-33% -$2.21M
DXCM icon
55
DexCom
DXCM
$29.1B
$4.69M 0.07%
252,732
-34,016
-12% -$503K
BMRN icon
56
BioMarin Pharmaceuticals
BMRN
$11.9B
$4.58M 0.07%
56,512
-168
-0.3% -$14.4K
XENT
57
DELISTED
Intersect ENT, Inc
XENT
$4.36M 0.07%
111,033
-14,857
-12% -$543K
NUVA
58
DELISTED
NuVasive, Inc.
NUVA
$4.27M 0.07%
81,851
-10,593
-11% -$537K
HZNP
59
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.99M 0.06%
281,300
-61,594
-18% -$910K
AERI
60
DELISTED
Aerie Pharmaceuticals
AERI
$3.95M 0.06%
72,739
-9,449
-11% -$528K
AIMT
61
DELISTED
Aimmune Therapeutics
AIMT
$3.92M 0.06%
123,283
-417
-0.3% -$14.7K
NVCR icon
62
NovoCure
NVCR
$1.78B
$3.67M 0.06%
168,321
-22,479
-12% -$483K
EXAS
63
DELISTED
Exact Sciences
EXAS
$3.58M 0.05%
88,693
+15,383
+21% +$750K
KTWO
64
DELISTED
K2M Group Holdings, Inc
KTWO
$3.54M 0.05%
186,882
-44,486
-19% -$881K
HOLX
65
DELISTED
Hologic
HOLX
$3.32M 0.05%
+88,877
New +$3.59M
RARE icon
66
Ultragenyx Pharmaceutical
RARE
$2.49B
$3.16M 0.05%
61,977
-9,463
-13% -$477K
HRTX icon
67
Heron Therapeutics
HRTX
$92.4M
$3.15M 0.05%
114,010
-17,590
-13% -$399K
OTEX icon
68
Open Text
OTEX
$6.23B
$3.11M 0.05%
69,300
– –
INCY icon
69
Incyte
INCY
$25.3B
$3.07M 0.05%
36,875
-13,301
-27% -$1.2M
ZVRA icon
70
Zevra Therapeutics
ZVRA
$575M
$3.06M 0.05%
24,230
-2,991
-11% -$289K
PTLA
71
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.02M 0.05%
92,599
-12,072
-12% -$530K
GWPH
72
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.9M 0.04%
25,710
-3,480
-12% -$438K
ITCI
73
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.89M 0.04%
137,403
-85,107
-38% -$1.66M
TVRD
74
Tvardi Therapeutics
TVRD
$22.1M
$2.87M 0.04%
6,438
-990
-13% -$480K
ONCE
75
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.78M 0.04%
41,774
-6,277
-13% -$362K
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q1 2018 Portfolio in Review

As of Q1 2018, C WorldWide Group held 128 positions worth $6.51B, down 5.8% from $6.92B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

C WorldWide Group withdrew a net $428M in Q1 2018, closing 2 positions and reducing 80 holdings. Its most notable exit was AutoZone, an estimated $595K position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, C WorldWide Group opened a new position in Becton Dickinson worth $11.5M.

  • C WorldWide Group's largest Q1 2018 buy was Becton Dickinson: 54,279 shares worth $11.5M.
  • C WorldWide Group added most to Alibaba in Q1 2018, an estimated $4.81M increase.
  • C WorldWide Group's biggest Q1 2018 reduction was Booking.com, cutting an estimated $215M.
  • C WorldWide Group fully exited AutoZone in Q1 2018, selling an estimated $595K.
  • C WorldWide Group's ten largest holdings make up 76% of its $6.51B portfolio in Q1 2018.
  • C WorldWide Group opened 5 new positions and closed 2 in Q1 2018.
  • C WorldWide Group's portfolio value fell 5.8% quarter-over-quarter to $6.51B.

Based on C WorldWide Group's 13F filing for Q1 2018, filed 3 May 2018.